To determine whether autologous hematopoietic stem cell transplantation (aHSCT) is able to induce durable disease remission in people with multiple sclerosis (MS), we analyzed the long-term outcomes after transplant in a large cohort of MS patients.

Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Capobianco, Marco;De Gobbi, Marco;Bertolotto, Antonio;Uccelli, Antonio;
2021-01-01

Abstract

To determine whether autologous hematopoietic stem cell transplantation (aHSCT) is able to induce durable disease remission in people with multiple sclerosis (MS), we analyzed the long-term outcomes after transplant in a large cohort of MS patients.
2021
10.1212/WNL.0000000000011461
x
Boffa, Giacomo; Massacesi, Luca; Inglese, Matilde; Mariottini, Alice; Capobianco, Marco; Lucia, Moiola; Amato, Maria Pia; Cottone, Salvatore; Gualandi...espandi
File in questo prodotto:
File Dimensione Formato  
NEUROLOGY-2020-096313v3-Inglese.pdf

Open Access dal 22/01/2022

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 303.24 kB
Formato Adobe PDF
303.24 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1770694
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 36
social impact